SCHEMBL20937136

SCHEMBL20937136

COc1c(C)cnc(CN(C(=O)OC(C)(C)C)c2cccc(CO[Si](C)(C)C(C)(C)C)c2)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC8 Q9BY41 1/20 0.38
AGXT P21549 1/20 0.36
F2RL3 Q96RI0 1/20 0.34
HSP90AA1 P07900 2/20 0.32
KMT2A Q03164 3/20 0.31
MEN1 O00255 2/20 0.31
F2 P00734 2/20 0.31
NR1H4 Q96RI1 1/20 0.31
PDE10A Q9Y233 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
BCL2 P10415 1/20 0.30
SHMT2 P34897 1/20 0.30
WDR5 P61964 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914535 0.90 AGXT (0.38) AGXTHSP90AA1KMT2AMEN1PDE10A
SCHEMBL19512937 0.87 HDAC1 (0.39) HDAC1HDAC6HDAC8AGXTHSP90AA1
SCHEMBL19512876 0.86 KMT2A (0.42) HDAC1HDAC6HDAC8AGXTHSP90AA1
SCHEMBL19512701 0.84 HDAC1 (0.41) HDAC1HDAC6HDAC8AGXTHSP90AA1
SCHEMBL20937663 0.84 AGXT (0.34) HDAC1HDAC6HDAC8AGXTBCL2
SCHEMBL20914591 0.84 KMT2A (0.41) HDAC1HDAC6HDAC8HSP90AA1KMT2A
SCHEMBL19512757 0.84 HDAC1 (0.40) HDAC1HDAC6HDAC8AGXTKMT2A
SCHEMBL20936992 0.83 HDAC1 (0.51) HDAC1HDAC6HDAC8AGXTF2
SCHEMBL19512769 0.83 HDAC1 (0.40) HDAC1HDAC6HDAC8AGXTKMT2A
SCHEMBL19512669 0.83 HDAC1 (0.40) HDAC1HDAC6HDAC8AGXTHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH HDAC1 1011/4885HDAC6 860/4885HDAC8 1139/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC HDAC1 1111/4885HDAC6 1082/4885HDAC8 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.